New imaging clues could help tailor breast cancer care

This study is testing whether a detailed PET/MR scan using a radioactive tracer called fluorocholine can predict the molecular subtype and likely outcomes of breast cancer. Researchers will scan 195 women before they start treatment and compare the images with their actual tumor type and response. The goal is to see if this imaging approach can help doctors choose the best treatment for each patient without needing extra biopsies.